213 related articles for article (PubMed ID: 24532572)
41. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
Muntner P; Carey RM; Gidding S; Jones DW; Taler SJ; Wright JT; Whelton PK
Circulation; 2018 Jan; 137(2):109-118. PubMed ID: 29133599
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
[TBL] [Abstract][Full Text] [Related]
43. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.
Payeras AC; Sladek K; Lembo G; Alberici M
Clin Drug Investig; 2007; 27(9):623-32. PubMed ID: 17705571
[TBL] [Abstract][Full Text] [Related]
44. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
45. Body mass index modulates blood pressure heritability: the Family Blood Pressure Program.
Simino J; Shi G; Weder A; Boerwinkle E; Hunt SC; Rao DC
Am J Hypertens; 2014 Apr; 27(4):610-9. PubMed ID: 24029162
[TBL] [Abstract][Full Text] [Related]
46. Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension.
Hwang AY; Dave CV; Smith SM
Am J Hypertens; 2018 Nov; 31(12):1324-1331. PubMed ID: 30052747
[TBL] [Abstract][Full Text] [Related]
47. Target Blood Pressure in Patients with Diabetes: Asian Perspective.
Park S; Kario K; Park CG; Huang QF; Cheng HM; Hoshide S; Wang JG; Chen CH;
Yonsei Med J; 2016 Nov; 57(6):1307-11. PubMed ID: 27593856
[TBL] [Abstract][Full Text] [Related]
48. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
49. Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With Hypertension.
Bromfield SG; Ngameni CA; Colantonio LD; Bowling CB; Shimbo D; Reynolds K; Safford MM; Banach M; Toth PP; Muntner P
Hypertension; 2017 Aug; 70(2):259-266. PubMed ID: 28652459
[TBL] [Abstract][Full Text] [Related]
50. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
[TBL] [Abstract][Full Text] [Related]
51. [Arterial hypertension, antihypertensive therapy, and visit-to-visit blood pressure variability of elderly nursing home residents].
Könner F; Kuhnert R; Budnick A; Kolloch R; Scholze J; Dräger D; Kreutz R
Dtsch Med Wochenschr; 2014 Nov; 139(48):2441-7. PubMed ID: 25409401
[TBL] [Abstract][Full Text] [Related]
52. Associations of Nocturnal Blood Pressure With Cognition by Self-Identified Race in Middle-Aged and Older Adults: The GENOA (Genetic Epidemiology Network of Arteriopathy) Study.
Yano Y; Butler KR; Hall ME; Schwartz GL; Knopman DS; Lirette ST; Jones DW; Wilson JG; Hall JE; Correa A; Turner ST; Mosley TH
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079569
[TBL] [Abstract][Full Text] [Related]
53. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey.
Wang J; Zhang L; Wang F; Liu L; Wang H;
Am J Hypertens; 2014 Nov; 27(11):1355-61. PubMed ID: 24698853
[TBL] [Abstract][Full Text] [Related]
54. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
[TBL] [Abstract][Full Text] [Related]
55. Potential impact of systematic and random errors in blood pressure measurement on the prevalence of high office blood pressure in the United States.
Sakhuja S; Jaeger BC; Akinyelure OP; Bress AP; Shimbo D; Schwartz JE; Hardy ST; Howard G; Drawz P; Muntner P
J Clin Hypertens (Greenwich); 2022 Mar; 24(3):263-270. PubMed ID: 35137521
[TBL] [Abstract][Full Text] [Related]
56. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
Lacourcière Y; Neutel JM; Davidai G; Koval S
Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
[TBL] [Abstract][Full Text] [Related]
57. A summary of the effects of antihypertensive medications on measured blood pressure.
Wu J; Kraja AT; Oberman A; Lewis CE; Ellison RC; Arnett DK; Heiss G; Lalouel JM; Turner ST; Hunt SC; Province MA; Rao DC
Am J Hypertens; 2005 Jul; 18(7):935-42. PubMed ID: 16053990
[TBL] [Abstract][Full Text] [Related]
58. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Ruilope LM; Usan L; Segura J; Bakris GL
J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814
[TBL] [Abstract][Full Text] [Related]
59. Genetic and environmental influences on blood pressure and body mass index in Han Chinese: a twin study.
Wu T; Snieder H; Li L; Cao W; Zhan S; Lv J; Gao W; Wang X; Ding X; Hu Y
Hypertens Res; 2011 Feb; 34(2):173-9. PubMed ID: 21048779
[TBL] [Abstract][Full Text] [Related]
60. A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration.
Shahin MH; Gong Y; McDonough CW; Rotroff DM; Beitelshees AL; Garrett TJ; Gums JG; Motsinger-Reif A; Chapman AB; Turner ST; Boerwinkle E; Frye RF; Fiehn O; Cooper-DeHoff RM; Kaddurah-Daouk R; Johnson JA
Hypertension; 2016 Sep; 68(3):621-9. PubMed ID: 27381900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
